Results for tag: "Ulcerative Colitis Drug"

The Ulcerative Colitis Drug market is a subset of the Gastrointestinal Drugs market, which includes medications used to treat a variety of gastrointestinal disorders. Ulcerative Colitis Drugs are used to treat the chronic inflammatory bowel disease of the same name. These drugs are typically administered orally or intravenously, and can be used to reduce inflammation, improve symptoms, and induce and maintain remission. Commonly prescribed Ulcerative Colitis Drugs include aminosalicylates, corticosteroids, immunomodulators, and biologics. The Ulcerative Colitis Drug market is highly competitive, with many companies offering a variety of treatments. Some of the major players in the market include AbbVie, Pfizer, Takeda, Janssen, and UCB. Show Less Read more